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Introduction: Stigma is a known correlate of well-being for many neurological 
conditions. Perceived control is also an important variable in models of adaptation to 
living with a health condition. The purpose of this study was to investigate whether 
the perception of control mediates the relationship between stigma and well-being in 
people with Parkinson’s disease.  
Methods: Two hundred and twenty-nine individuals completed quantitative measures 
of stigma and perceived control, and a full exploration of the concept of well-being 
(including health-related quality of life, depression, anxiety, stress and positive 
affect). A series of mediation models investigated whether perceived control 
mediated the relationship between stigma and each measure of well-being.  
Results: Mediational regression analyses indicated that the perception of control 
mediated the relationship between stigma and health-related quality of life, 
depression and positive affect. Perceived control did not, however, mediate the 
relationship between stigma and anxiety nor between stigma and stress. 
Conclusions: These findings suggest that in people with Parkinson’s disease, 
perceived control may play an important role in explaining the relationship between 
stigma and some aspects of well-being. Both stigma and perceived control should be 
considered within clinical and everyday environmental settings for individuals with 
Parkinson’s disease. Interventions which focus on both reducing stigma and 






1. Introduction  
People with Parkinson’s disease (PD) often have visible physical differences 
(e.g., tremor, rigidity, dykinesias) as well as difficulties with cognition and 
communication. Such differences have long been known to attract stigma [1]. Classic 
accounts of stigma suggest it occurs in response to characteristics that deviate from 
the social norm and are considered to be of less value [e.g. [2]. Stigma can involve 
direct acts from others (e.g. being called derogatory names, or being stared at), 
known as enacted stigma as well as being felt as a result of anticipating such 
reactions and internalising negative societal stereotypes, known as felt stigma [3]  
People with PD describe a variety of stigmatising experiences, including 
feeling shame and embarrassment due their difficulties, increased social isolation 
due to worries regarding others’ perceptions and feeling a burden to others [4]. 
However, the relationship between stigma and psychological well-being is complex. 
For some individuals with PD, there appears to be an association between stigma 
experiences and high anxiety and depression e.g. [5, 6]. For others, the experience 
of stigma does not appear to correlate with anxiety [7] nor positive affect [6]. 
Therefore, there may be other factors that influence the effect of stigma on indices of 
well-being.   
One variable which might explain the differing effects of stigma on measures 
associated with well-being is perceived control, understood as the level of control felt 
by an individual generally (i.e. over their life) or, as is more relevant in this context, in 
health-related domains. Control as a concept has been extensively used as both a 
predictor and outcome measure [8], is included in a number of theoretical models on 
adaptation to chronic illness (e.g. self-regulatory model [9]) and has been shown to 





important caveats) predicting higher levels of well-being. For individuals with chronic 
health conditions, high levels of perceived control are generally associated with high 
scores of health-related quality of life (HRQoL) and low levels of anxiety, depression 
and negative affect [10, 11].   
Obtaining a sense of perceived control over PD is challenging due to the 
chronic, unpredictable and degenerative nature of the condition, with people with PD 
reporting loss of self-efficacy and autonomy [4]. However, it is possible for individuals 
with PD to gain a sense of control over some aspects of treatment and/or over other 
aspects of their lives [8, 12]. Given the significance of perceived control for 
individuals with PD, it could be hypothesised that perceived control underpins the 
relationship between stigma and well-being and so acts as an important mediating 
variable.  
It is accepted that well-being is a well-used term with no fixed and agreed 
definition e.g. [13] but is operationalised in this study by both the absence of mental 
health difficulties (i.e. as measured by depression and anxiety scales) and by the 
presence of positive affect. Consequently, the models tested whether perceived 
control mediates the relationship between stigma and measures of well-being. 
Specifically, it was predicted that low levels of stigma would be associated with high 
levels of well-being and perceived control and that perceived control would mediate 




All participants were recruited from a large UK-based PD charity (Parkinson’s 





December 2017. While online recruitment methods have some limitations (e.g., 
inability to confirm diagnosis definitively), they have been used extensively 
elsewhere – e.g. in studies validating quality of life [14]. Individuals who met the 
following inclusion criteria were eligible to participate in the study: 
• Self-reported a diagnosis of PD. 
• Aged 18 years or above. 
• Sufficient knowledge of written English to take part.  
• Could complete the survey measures either alone or with support.  
2.2 Design 
The study was a cross-sectional survey comprised of quantitative measures. 
The data were examined using mediation analysis conducted using Hayes 
PROCESS tool [15] to examine whether perceived control mediated the relationship 
between stigma and well-being. A path diagram is shown in figure 1.  




























Parameters a, b and c’ denote path (regression) coefficients. 
 
Ethical approval was given by the researchers’ host academic institution 
(Reference: FHMREC16123). All participants provided consent to participate in the 
study. At least 71 participants were required to provide 80% power (p <.05) [16].  
2.3 Materials 
The survey included demographic and clinical questions alongside validated 
measures. The demographic variables collected were age, gender, ethnicity, work 
status, relationship status and living arrangements (alone, co-habiting, 
residential/nursing home). The clinical variables collected were age of symptom 
onset, age of diagnosis and whether taking medication.  
2.4 Validated Measures 
2.4.1 Predictor Variable  
The 24-item Stigma Scale for Chronic Illness (SSCI) [17] measures both 
perceived (or felt) stigma and enacted stigma and has been validated for use with 
individuals with neurological conditions such as PD. The scale consists of two 
subscales which measures the two stigma concepts. The perceived stigma subscale 
contains 13 items about an individual’s feelings regarding their condition, focusing on 
any worries or feelings of embarrassment. The enacted subscale consists of 11 
items and questions relate to an individual’s objective experience of stigma such as 
noticing people staring. Scores on the two subscales are summed to create a total 





2.4.2 Mediator Variables 
The 15-item Parkinson’s UK Scale of Perceived Control (PUKSoPC) was 
developed with Parkinson’s UK members and has been comprehensively validated 
[18]. The scale consists of five subscales: Think positive, Get informed, Do things, 
Make plans, and Be involved, which are summed to give the total score, used here. 
Higher scores indicate greater perceived control.  
The 10-item General Self-Efficacy Scale (GSE) [19] was used as a 
general/non-health specific measure of perceived control. It assesses individuals’ 
general beliefs in their ability to respond to and problem solve situations; higher 
scores indicate higher self-efficacy. It was used as a comparator measure to the 
above scale.  
2.4.3 Outcome Variables 
The 8-item Parkinson’s Disease Questionnaire short form (PDQ8) was used 
to measure HRQoL [20, 21]. Lower scores indicate higher HRQoL.  
The Depression Anxiety and Stress Scale-21 (DASS-21) [22] is a well-
validated short-form version of the original 42-item scale. It consists of three 
subscales: depression, anxiety, and stress, with higher scores indicating more 
severe depression, anxiety or stress.  
The 10-item positive subscale of the Positive and Negative Affect Schedule 
(PANAS) [23] was used to measure positive affect in the last few weeks (the DASS 
already provided an assessment of negative mood). Higher scores indicate greater 





2.5 Missing data 
The missing data within the dataset were minimal (less than 5%). Twenty 
entries provided only demographic information and/or limited completion of 
measures and were removed [24]. Given the small amount of missing data, methods 
of mean imputation and pro-rating of individual cases was used for n = 14 [24]. One 
extreme data point was removed, leaving 229 participants in the overall data set.  
 
2.6 Inferential analysis 
Normality of the data was assessed and as some variables (particularly the 
DASS) were skewed, Spearman’s correlation coefficients were conducted between 
each outcome variable and demographic/psychosocial variables. The data were then 
statistically examined using a mediational regression and only significant correlations 
(p < .05) were entered into the model [24]. Hayes PROCESS tool [15], which 
implements a bias-corrected bootstrap model, was utilised to conduct the mediation 
regression (with 1000 replications). Each regression which formed part of the 
mediation was tested to ensure assumptions of linearity, and normality and 




Demographic and clinical details can be seen in Table 1 and means, standard 
deviations (SD) and Cronbach’s alpha of psychometric measures in Table 2. The 
mean of the sample indicated generally low levels for depression (in the mild range); 





within the normal range [25]. The means were somewhat higher (indicating greater 
distress) than some previous Parkinson’s disease studies [26, 27]. Using cut-offs in 
the manual [25], the proportions of the sample in the different categories were as 
follows: depression (normal 55%, mild 13.1%, moderate 17.5%, severe 6.1%, very 
severe 8.3%), anxiety (normal 32.8%, mild 13.5%, moderate 26.6%, severe 10.5%, 
very severe 16.6%) and stress (normal 61.6% , mild 14.8%, moderate 9.2%, severe 
9.6%, very severe 4.8%). The mean PDQ8 was moderately low compared to the 
validation sample (indicating a higher HRQoL) but comparable to those in the 
validation sample at Hoehn and Yahr stage 2 [21, 28]. On the PANAS, positive affect 
was comparable to a UK general population validation sample [29], comparable to 
some previous Parkinson’s disease samples [30, 31] but higher than others [27].  
 
Table 1 Descriptive statistics of the sample  
  
 Value Range 
Age: mean (SD)   
Age in years 65 (8.00) 29-90 
Age of symptom onset 57 (9.74) 26-90 
Age of diagnosis 60 (9.32) 29-90 
Gender: n (%)   
Female 116 (51) - 
Male 113 (49) - 
Ethnic group: n (%)   
White  227 (91) - 
Asian 2 (9) - 
Partnership status: n (%)   
Single 18 (8) - 





Divorced 10 (4) - 
Widowed 10 (4) - 
Living arrangements: n (%)   
Alone 37 (16) - 
With others (partners, family and friends) 190 (83) - 
Residential/nursing home 1 (0.5) - 
Other 1 (0.5) - 
Work Status:   
Employed 42 - 
Other (including retired) 187 - 
SD = standard deviation. Percentages are rounded to the nearest whole number, 
except for percentages less than one, which are rounded to the nearest 0.5%. 
 
Table 2: Mean, standard deviation and correlates of variables 
 
SSCI PUKSoPC GSE PDQ DASS-D DASS-A DASS-
S 
PANAS 
Mean 50.13 56.53 29.42 31.11 10.56 11.39 14.07 32.56 
SD 15.70 10.18 6.33 20.63 10.13 7.78 9.51 9.27 
Cronbach’
s alpha 
0.94 0.89 0.94 0.85 0.92 0.72 0.88 0.93 
         
Age -0.11 0.12 0.05 0.04 -0.03 -0.09 -0.10 0.06 
Gender 0.10 0.04 -.016* 0.00 -0.01 0.02 0.01 -0.02 
Work 
status 
-0.06 .202** 0.02 0.05 -0.02 -0.10 0.00 0.10 
Relationsh
ip status 
0.11 -.15* -0.11 0.11 .15* .15* .18** -0.13 
Living 
status 




-0.24** 0.07 0.14* -0.15* -0.11 -0.14* -0.14* 0.09 
Age of 
diagnosis 
-0.25** 0.09 0.14* -0.14* -0.12 -0.13* -0.11 0.09 
Disease 
duration 









SSCI - -0.37** -0.37** 0.68** 0.61** 0.49** 0.54** -0.41** 
PUKSoPC -  0.51** -0.37** -0.50** -0.22** -0.30** 0.66**  
GSE - - - -.005** -0.50** -0.30** -0.36** 0.66** 
SSCI = Stigma Scale for Chronic Illness; PUKSoPC = Parkinson’s UK Scale of 
Perceived Control; GSE = General Self-Efficacy Scale. *p value is less than .05. **p 
value is less than .01. DASS-21 scores are doubled to allow comparison with the full 
42 item DASS [25]. 
 
3.2 Correlational analyses  
Prior to mediation regression, bivariate Spearman’s correlations were carried 
out on the demographic and psychosocial variables (see Table 2 for details).  
The stigma scale, the SSCI, correlated in the expected direction with the 
measures of depression, anxiety, stress, HRQoL and positive affect (DASS; PDQ; 
PANAS); higher stigma was associated with lower well-being. Significant negative 
correlations were found between the SSCI and both measures of perceived control 
(PUKSoPC; GSE); thus higher stigma scores were associated with lower scores of 
perceived control. Significant relationships in the predicted direction were found 
between both measures of perceived control (PUKSoPC; GSE) and all psychological 
outcomes variables, i.e. higher control correlated with higher well-being.  
A number of demographic variables correlated with the outcome variables.  
Depression correlated with relationship status (those currently with a partner were 
less depressed than those not currently with a partner) and living status (those living 
with other/s were less depressed than those alone); anxiety correlated with 
relationship status (those with a partner were less anxious), age of symptom onset 
and diagnosis (higher age of onset/diagnosis, less anxiety); stress correlated with 
relationship status (those with a partner were less stressed), living status (those 
living with other/s were less stressed) and age of symptom onset (higher age of 





(higher age of onset/diagnosis, higher HRQoL) and disease duration (shorter 
duration, higher HRQoL). These demographic variables were consequently 
controlled within the regression models. 
3.3 Mediation analyses 
Given the support from examination of the correlational analysis for the hypothesised 
mediation model, full mediational regression analyses were performed and then re-
examined while controlling for covariates. As the outcomes controlling for covariates 
were very similar, for clarity only the results of the unadjusted analyses are shown in 
Tables 3 (with PUKSoPC as control variable) and 4 (with GSE as control variable). 
3.3.1 Mediation with PUKSoPC as mediator 
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0.26** 0.23** 0.32** 0.30** -0.13** 





0.02 0.003 0.07 0.02 -0.14 
CI 0.01, 0.05 -0.03, 
0.03 







CSIE 0.06 - 0.11 - -0.23 
CI = confidence interval; CSIE = completely standardised indirect effect. * p < .05  ** 
p < .001.  
 
Mediation analyses indicated that perceived control was found to be a 
significant mediator between stigma and HRQoL (ab = 0.02, 95% CI [0.01, 0.05]). 
The direct effect between stigma and HRQoL remained significant when controlling 
for the effect of the mediational variable of perceived control (c’ = 0.26, 95% CI [0.22, 
0.31], p < .001). The completely standardised indirect effect indicated that as stigma 
scores increased by 1 SD, HRQoL scores increased by 0.06 SD due to the effect of 
perceived control. When controlling for age of symptom onset and age of diagnosis, 
all pathways of the model remained significant and the completely standardised 
indirect effect remained the same (0.06).  
Similarly, perceived control was a significant mediator for the relationship 
between stigma and depression (ab = 0.07, 95% CI [0.03, 0.11]). The direct effect 
between stigma and depression remained significant when controlling for the effect 
of the mediational variable (c’ = 0.32, 95% CI [0.25, 0.39], p < .001). The completely 
standardised indirect effect was 0.11. When adjusting for relationship status and 
living arrangements, all pathways of the model remained significant and the 
completely standardised indirect effect reduced slightly to 0.10.  
Perceived control also mediated the relationship between stigma and positive 
affect (ab = -0.14, 95% CI [-0.19, -0.09]). The direct effect between stigma and 
positive affect remained significant when controlling for the effect of the mediator 





effect was -0.23. There were no significant demographic and clinical covariates for 
positive affect so an adjusted model was not required. 
Perceived control was not a significant mediator of the relationship between 
stigma and anxiety (ab = 0.003, 95% CI [-0.03, 0.03]). When adjusting for covariates 
symptom onset and relationship status, the non-significant finding remained. 
Similarly perceived control was not a significant mediator of the relationship between 
stigma and stress (ab = 0.02, 95% CI [-0.01, 0.06]). When adjusting for covariates 
living arrangements and relationship status and age of symptom onset, the non-
significant finding remained. 
 
3.3.2 Mediation with GSE as mediator 
Table 4 Mediation Models with stigma as predictor (X) and GSE as mediator (M)  
 
Model 1 
Y = HRQoL 
Model 2 
Y = anxiety 
Model 3 
Y = depression 
Model 4 
Y = stress 
Model 5 
Y = positive 
affect 
      
A -0.16** -0.16** -0.16** -0.16** -0.16** 
CI -0.21, -0.11 -0.21, -0.11 -0.21, -0.11 -0.21, -
0.11 
-0.21, -0.11 
      
B -0.27** -0.14 -0.46** -0.17 0.89** 
CI -0.37, -0.17 -0.29, 0.02 -0.63, -0.29 -0.35, 0.01 0.74, 1.03 




0.25** 0.21** 0.31** 0.29** -0.12** 
CI 0.21, 0.29 0.15, 0.27 0.24, 0.38 0.22, 0.36 -0.18, -0.07 




0.04 0.01 0.07 0.02 -0.14 
CI 0.02, 0.07 -0.01, 0.03 0.03, 0.12 -0.01, 0.07 -0.20, -0.09 





CI = confidence interval; CSIE: completely standardised indirect effect. * p < .05. ** p 
< .001.  
 
As can be seen from Table 4, the finding using the GSE scale as a measure of 
control were very similar to those using the PUKSoPC. Again, perceived control 
mediated the relationship between stigma and health-related quality of life, 
depression and positive affect. It did not mediate the relationship between stigma 
and anxiety or stress. The findings when controlling for covariates were similar (the 
same paths remained significant). 
4. Discussion 
This study examined whether the perception of control played a mediating 
role in the relationship between stigma and a broad conceptualisation of well-being 
including HRQoL and standard indices of mood and positive affect. Stigma 
significantly correlated with all outcome measures in the expected direction (greater 
stigma, poorer well-being), with moderate effects between stigma and perceived 
control, positive affect and anxiety and large ones between stigma and stress, 
depression and HRQoL. Perceived control significantly mediated the relationship 
between stigma and HRQoL, depression and positive affect. All pathways within 
these models were significant, including when covariates were controlled. The 
largest completely standardised effect size was for the mediated relationship 
between stigma and positive affect. However, perceived control did not mediate the 
relationship between stigma and anxiety and stress.  
The mediating effect of perceived control supports the importance placed 
upon it within health behaviour models such as Leventhal’s self-regulatory model 





beliefs may facilitate adjustment to a health condition. Control is an important 
component of these beliefs and the model cumulatively can explain the various 
influences on and responses to a chronic condition such as PD [see [10] for review]. 
In addition, the current findings provide further support to the growing literature that 
emphasises the role of perceived control particularly for those with PD [8]. 
From a theoretical perspective, the association between (perceived) 
(un)controllability and depression has long been established. For example, learned 
helplessness may arise as a result of having limited or no control and this state has 
been associated with negative affect and is often considered to lead to depression 
[32]. However, both measures of perceived control (PUKSoPC; GSE) were more 
weakly associated with anxiety. While initially surprising, these findings are 
consistent with some previous research which reports a weak or no association 
between perceived control and anxiety when measured cross-sectionally [27, 33]. 
However Evans and Norman [33] found perceived control at baseline predicted 
anxiety six months later, when controlling for baseline anxiety, and therefore the 
relationship between perceived control and anxiety may be more complex and 
involve longitudinal effects.   
Given the findings, interventions should acknowledge the effect of stigma, 
through the direct pathway and the indirect pathway, via perceived control. Reducing 
stigma is complicated and requires coordinated effort on a number of levels including 
intrapersonal, interpersonal, community, organisational and governmental change 
[34]. Intrapersonal interventions can target a variety of factors including knowledge, 
attitudes, emotions and behaviour as well as improving coping skills [34] which may 
both reduce stigma and improve perceived control. For example, cognitive-





stigma in other conditions [34] and, while the stigma reduction has not been proven 
in PD, such intrapersonal factors are also targeted in CBT for people with PD [35]. 
More generally, psychological therapy has been shown to increase self-efficacy (and 
therefore perceived control) for people with other neurological conditions, including 
when used in groups [36].  Furthermore, self-help and advocacy groups may also be 
beneficial to target these intrapersonal factors, alongside working with local 
communities and families to increase social support [34].  
However, individual interventions are frequently criticised for proposing the 
stigmatised individual as the agent of change, rather than placing the responsibility 
for such change into society. Indeed it can be society which has actively lead to the 
stigmatisation and diminution of control [37]. Thus there are calls for more research 
into interventions at wider organisational, community and societal levels [34]. 
Educational campaigns are needed to increase understanding in communities along 
with societal and legal changes which promote social inclusion and reduce 
discriminatory practices [34]. 
By measuring HRQoL in more depth, future research could examine whether 
one of the components of stigma predicts certain dimensions of HRQoL (e.g. 
enacted stigma could predict activities of daily living). With a greater understanding 
of stigma (i.e. its separate forms and how these are related to the individual 
components of HRQoL) interventions may be tailored more appropriately, at either 
an individual or societal level. For example, if enacted stigma plays a significant role 
in HRQoL, it may be more appropriate to increase awareness and understanding of 
the nature of PD through various media channels.  
The study has a number of limitations. It used online recruitment and was 





who may be highly literate and/or motivated due to the fact that they have proactively 
become a member of a third-sector organisation. Therefore, the findings could be 
different for individuals with PD who do not have computer access or are not 
members of a charity. The study was only available in English, and although 
individuals were permitted to complete the survey with support, comprehending the 
survey and the concept of stigma may not be translatable to other languages or 
cultures.  
Given the cross-sectional design of the study, the findings provide a snapshot 
of how perceived control may affect the relationship between stigma and variables of 
HRQoL. However, as it is cross-sectional, the direction of the relationships is not 
assured. Relationships may be bi-directional whereby, for example, lower mood also 
leads to reduced perceived control and an increased sensitivity to notice 
discrimination as well as a feeling of increased stigmatisation. Lower perceived 
control may also lead to greater feelings of stigma and hence lower wellbeing. 
Longitudinal studies would be needed to tease out further the temporal nature of 
these interactions. Furthermore, with a progressive condition, such as PD, the 
condition may become more visible and therefore more visible to others. Increasing 
visibility may result in higher experiences of stigma [1]. The experience of perceived 
control may also change over time with a changing course of the condition [11]. 
Longitudinal studies may also provide a more detailed picture of how these 
relationships may change over time.  
5. Conclusion 
Both stigma and perceived control are associated with quality of life and 





quality of life and greater control predicts less distress and improved quality of life). 
Furthermore, perceived control plays an important role in mediating the relationship 
between stigma and HRQoL, stigma and depression and stigma and positive affect. 
Interventions should target both control and stigma, not just at an individual level but 
also systemically to help enhance individuals’ HRQoL and aspects of emotional well-
being. Future research should further examine stigma and its defined forms with the 
individual components of HRQoL, to elucidate the relationships further. In addition, 
larger samples would enable the examination of more complex relationships and 
longitudinal studies would help clarify the nature of the relationships over time. 
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